Tandem Diabetes has completed the previously announced deal for AMF Medical, Swiss developer of the Sigi patch pump.
 
Sigi aims to be an ergonomic, rechargeable patch pump to reduce the burden of managing diabetes via prefilled insulin cartridges. The technology is currently under development and not commercially available.
 
“AMF Medical’s compelling technology aligns well with our strategic vision to include a patch pump in Tandem’s portfolio of differentiated offerings,” John Sheridan, Tandem Diabetes Care president and CEO told the press. “In addition to this innovative technology, the talented AMF team joining our Tandem family shares our commitment to simplify diabetes management and brings decades of experience from the diabetes device, life sciences, and watch-making industries.”
 
“AMF Medical was founded to develop a patch pump that is not only simple to use for people with diabetes, but also optimized for scale manufacturing,” said Peter Ryser, AMF Medical’s chairman and co-founder.
 
“We are thrilled that our work will be carried forward by a mission-driven company like Tandem,” added Antoine Barraud, co-Founder and co-CEO, noting that “Tandem not only shares our deep-rooted dedication to diabetes technology, but has created an incredibly user-focused culture that is very well aligned with our company values.”